AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
源站原文 ↗AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
源站原文 ↗中文加工失败;以上为源提供文本,来源与回链未受影响。
摘要不可用(正文抓取失败或尚未完成);源提供文本与源站链接见左列。